ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Creative Proteomics Launches SPR-based Biacore Service to Help Study Biomolecular Interactions

By: Get News

New York, USA - December 26, 2022 - Creative Proteomics is an integrated CRO company committed to providing a full range of services in order to support various proteomic research projects, covering the identification of single proteins to large-scale proteomic studies. The company introduces the high-quality Biacore service based on its powerful Surface Plasmon Resonance (SPR) technology for label-free and real-time analysis of any interacting molecule pairs, including small molecule drugs bound to targeted proteins.

The SPR assay provides a method for determining the affinity and binding kinetics of a ligand to its receptor and measures the real-time binding association and dissociation rates. In utilizing this strategy, one of the binding partners (e.g., receptor protein) is immobilized on a biosensor surface. In contrast, the other partner, e.g., drug ligand, is continuously flown across the biosensor surface and binds to the immobilized receptor. Binding is measured as a change in resonance units (RUs) on the biosensor surface, and measuring the upregulation of bounded ligands over time at a given ligand concentration reveals the ligand association rate (ka or Kon). Ceasing the flow of the drug ligand and switching buffer alone allows the ligand to wash off from the receptor. Meanwhile, measuring the downregulation of bounded ligands over time reveals the ligand dissociation rate (kd or Koff). The affinity of the ligand for the receptor (the equilibrium dissociation constant, KD) is calculated based on these kinetic association rates and dissociation rates (kd/ka) by using multiple ligand concentrations.

The Biacore platform can provide detailed information on bispecific binding interactions and kinetic studies without the use of marker molecules. While the response curve of the system is displayed during the course of analysis, the change of resonance is susceptible to the changes at the surface of the sensor chip. The sensor chip is a vital part of the Biacore platform, which determines the system's sensitivity. Molecules can be immobilized on the surface of the sensor chip through different approaches, such as high-affinity capture (non-covalent interaction), covalent chemical interaction, and hydrophobic adsorption. Hence, this sensor chip has various functions to meet the needs and requirements of different projects.

Strategies for target analyte capturing rely on the interaction between the analyte and the ligand on the sensor surface. Some common capturing approaches are streptavidin/avidin-biotin interaction, antibody-antigen interaction, and tagged recombinant proteins based capturing.

"Over the years, Creative Proteomics has acquired expertise in the application of the Biacore SPR technology and has proven to be a reliable partner for clients in the pharmaceutical industry as well as academic institutions for specific research projects. We are equipped with a wide range of SPR biosensors to ensure rapid and customized analysis of your samples according to a comprehensive work plan tailored to your specific needs," said a senior scientist of Creative Proteomics.

About Creative Proteomics

Creative Proteomics, an experienced proteomics, metabolomics, and bioinformatics services supplier, is well equipped with advanced technologies in order to meet the increasing needs of scientists in proteomics and metabolomics-related research.

Media Contact
Company Name: Creative Proteomics
Contact Person: Dora West
Email: Send Email
Phone: 1-631-593-0501
Country: United States
Website: https://www.creative-proteomics.com



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.